Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label early stage ovarian cancer. Show all posts
Showing posts with label early stage ovarian cancer. Show all posts
Saturday, April 07, 2012

abstract: Cochrane Review: Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer

›
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer [Cochrane Database Syst Rev. 2012] - PubMed - NCBI Cochran...
Saturday, March 17, 2012

Cochrane Review: Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer (abstract)

›
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer [Cochrane Database Syst Rev. 2012] Cochrane Database Syst...
Thursday, March 08, 2012

Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery

›
Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initi...
Monday, February 27, 2012

Press Release -grant award "SQUID Imaging for Detection of Early Stage Ovarian Cancer"

›
ALBUQUERQUE, N.M.--(BUSINESS WIRE)-- "The National Foundation for Cancer Research has awarded a grant to Dr. Robert C. Bast, Jr. of...
Thursday, March 24, 2011

Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery

›
Abstract Objective. To investigate the impact of perioperative capsule rupture on disease-free survival (DFS) and cancer-specific surviva...
Friday, May 14, 2010

2008 September CANO Survivors' Debate Presentation - authors Carolyn Benivegna & Sandi Pniauskas

›
primary authors:   Carolyn Benivegna (in spirit) & Sandi Pniauskas  clicking above will bring you directly to the presentation, ...
Thursday, April 15, 2010

Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Systemati Rev. 2010

›
Note: there are many different comments from a variety of healthcare professionals and more than a normal number of comments Abstract BA...
Saturday, February 06, 2010

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial

›
Conclusion: "Despite a favorable impact of carboplatin and PLD on progression-free survival in this trial, the effect on overall survi...

The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study

›
Abstract Objectives A prior clinical trial on early-stage high risk ovarian cancer showed a lower recurrence rate in those treated with si...